TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs9276615
log Bayes Factor = 49.5553
Chromosome 6   position 32,743,217  (GRCh37) Explore rs9276615 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.000 1.000
E03.9 Hypothyroidism, unspecified
0.000 0.000 1.000
M06.9 Rheumatoid arthritis, unspecified
0.000 0.000 1.000
G35 Multiple sclerosis
1.000 0.000 0.000
E00-E07 Disorders of thyroid gland
0.000 0.000 1.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.000 1.000
L40.5 Arthropathic psoriasis
0.000 0.000 1.000
M05-M14 Inflammatory polyarthropathies
0.000 0.000 1.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.000 1.000
E10 Insulin-dependent diabetes mellitus
0.000 0.000 1.000
M06 Other rheumatoid arthritis
0.000 0.000 1.000
E10-E14 Diabetes mellitus
0.000 0.000 1.000
M07.3 Other psoriatic arthropathies
0.000 0.000 1.000
C44 Other malignant neoplasms of skin
0.000 0.000 1.000
E03 Other hypothyroidism
0.000 0.000 1.000
M07 Psoriatic and enteropathic arthropathies
0.000 0.000 1.000
L57.0 Actinic keratosis
0.000 0.000 1.000
L40 Psoriasis
0.000 0.000 1.000
E05 Thyrotoxicosis [hyperthyroidism]
0.000 0.000 1.000
C44.7 Skin of lower limb, including hip
0.000 0.001 0.999
M05 Seropositive rheumatoid arthritis
0.000 0.001 0.999
M05.9 Seropositive rheumatoid arthritis, unspecified
0.000 0.001 0.999
E20-E35 Disorders of other endocrine glands
0.000 0.003 0.997
M07.39 Other psoriatic arthropathies (Site unspecified)
0.000 0.003 0.997
L40.9 Psoriasis, unspecified
0.000 0.003 0.997
C44.6 Skin of upper limb, including shoulder
0.000 0.004 0.996
E10.3 With ophthalmic complications
0.000 0.004 0.996
E05.9 Thyrotoxicosis, unspecified
0.000 0.004 0.996
C44.3 Skin of other and unspecified parts of face
0.000 0.004 0.996
M06.94 Rheumatoid arthritis, unspecified (Hand)
0.000 0.007 0.993
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.008 0.992
E23 Hypofunction and other disorders of pituitary gland
0.000 0.010 0.990
E05.0 Thyrotoxicosis with diffuse goitre
0.000 0.010 0.990
E10.9 Without complications
0.000 0.010 0.990
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)
0.000 0.010 0.990
G35-G37 Demyelinating diseases of the central nervous system
0.988 0.012 0.000
G37 Other demyelinating diseases of central nervous system
0.984 0.016 0.000
M07.30 Other psoriatic arthropathies (Multiple sites)
0.000 0.020 0.980
L40-L45 Papulosquamous disorders
0.000 0.022 0.978
G37.9 Demyelinating disease of central nervous system, unspecified
0.977 0.023 0.000
E11 Non-insulin-dependent diabetes mellitus
0.000 0.028 0.972
E70-E90 Metabolic disorders
0.000 0.029 0.971
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.030 0.970
L57 Skin changes due to chronic exposure to nonionising radiation
0.000 0.032 0.968
E83.1 Disorders of iron metabolism
0.952 0.048 0.000
E27 Other disorders of adrenal gland
0.000 0.049 0.951
E78.0 Pure hypercholesterolaemia
0.000 0.049 0.951
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue
0.000 0.051 0.949
E11.3 With ophthalmic complications
0.000 0.061 0.939
C44.4 Skin of scalp and neck
0.000 0.065 0.935
Chapter XII Diseases of the skin and subcutaneous tissue
0.000 0.066 0.934
E23.6 Other disorders of pituitary gland
0.000 0.068 0.932
E23.7 Disorder of pituitary gland, unspecified
0.000 0.073 0.927
C44.2 Skin of ear and external auricular canal
0.000 0.083 0.917
E27.1 Primary adrenocortical insufficiency
0.000 0.094 0.906
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.096 0.904
E78.5 Hyperlipidaemia, unspecified
0.000 0.100 0.900
M06.96 Rheumatoid arthritis, unspecified (Lower leg)
0.000 0.106 0.894
E06 Thyroiditis
0.000 0.110 0.890
E11.9 Without complications
0.000 0.110 0.890
M07.36 Other psoriatic arthropathies (Lower leg)
0.000 0.114 0.886
C44.0 Skin of lip
0.000 0.117 0.883
E10.5 With peripheral circulatory complications
0.000 0.119 0.881
M07.37 Other psoriatic arthropathies (Ankle and foot)
0.000 0.121 0.879
G37.8 Other specified demyelinating diseases of central nervous system
0.878 0.122 0.000
C43-C44 Melanoma and other malignant neoplasms of skin
0.000 0.125 0.875
L43 Lichen planus
0.000 0.128 0.872
E10.1 With ketoacidosis
0.000 0.141 0.859
M06.0 Seronegative rheumatoid arthritis
0.000 0.152 0.848
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.153 0.847
E89.0 Postprocedural hypothyroidism
0.000 0.154 0.846
E06.3 Autoimmune thyroiditis
0.000 0.157 0.843
E23.2 Diabetes insipidus
0.000 0.158 0.842
E10.0 With coma
0.000 0.162 0.838
E78.2 Mixed hyperlipidaemia
0.000 0.163 0.837
L40.1 Generalised pustular psoriasis
0.000 0.175 0.825
E78.6 Lipoprotein deficiency
0.000 0.181 0.819
E28 Ovarian dysfunction
0.000 0.187 0.813
M10 Gout
0.000 0.193 0.807
M07.34 Other psoriatic arthropathies (Hand)
0.000 0.198 0.802
M06.3 Rheumatoid nodule
0.000 0.199 0.801
L40.0 Psoriasis vulgaris
0.000 0.199 0.801
G36 Other acute disseminated demyelination
0.800 0.200 0.000
E04 Other non-toxic goitre
0.000 0.200 0.800
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.202 0.798
E78.1 Pure hyperglyceridaemia
0.000 0.203 0.797
E11.2 With renal complications
0.000 0.203 0.797
E88 Other metabolic disorders
0.000 0.208 0.792
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.210 0.790
E10.2 With renal complications
0.000 0.214 0.786
E29 Testicular dysfunction
0.000 0.214 0.785
E23.0 Hypopituitarism
0.000 0.218 0.782
D00-D09 In situ neoplasms
0.000 0.219 0.781
Chapter II Neoplasms
0.000 0.225 0.775
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.225 0.775
D04 Carcinoma in situ of skin
0.000 0.226 0.774
E24 Cushing's syndrome
0.000 0.228 0.772
E13 Other specified diabetes mellitus
0.000 0.228 0.772
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.232 0.768
M06.4 Inflammatory polyarthropathy
0.000 0.232 0.768
D06 Carcinoma in situ of cervix uteri
0.000 0.232 0.768
M06.92 Rheumatoid arthritis, unspecified (Upper arm)
0.000 0.233 0.767
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.000 0.233 0.767
L80-L99 Other disorders of the skin and subcutaneous tissue
0.000 0.237 0.763
L82 Seborrhoeic keratosis
0.000 0.241 0.759
L56 Other acute skin changes due to ultraviolet radiation
0.000 0.242 0.758
D06.9 Cervix, unspecified
0.000 0.242 0.758
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.000 0.244 0.756
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.245 0.755
L57.8 Other skin changes due to chronic exposure to nonionising radiation
0.000 0.250 0.750
M06.09 Seronegative rheumatoid arthritis (Site unspecified)
0.000 0.252 0.748
E11.1 With ketoacidosis
0.000 0.253 0.747
E26 Hyperaldosteronism
0.000 0.260 0.740
L43.9 Lichen planus, unspecified
0.000 0.263 0.737
E10.8 With unspecified complications
0.000 0.265 0.734
E84 Cystic fibrosis
0.000 0.266 0.733
L43.8 Other lichen planus
0.000 0.268 0.732
L40.4 Guttate psoriasis
0.000 0.270 0.730
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.271 0.729
L42 Pityriasis rosea
0.000 0.272 0.728
M06.98 Rheumatoid arthritis, unspecified (Other)
0.000 0.275 0.725
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.275 0.725
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.283 0.717
E00 Congenital iodine-deficiency syndrome
0.000 0.283 0.717
M09 Juvenile arthritis in diseases classified elsewhere
0.000 0.283 0.717
M08 Juvenile arthritis
0.000 0.283 0.717
E10.7 With multiple complications
0.000 0.283 0.717
M06.2 Rheumatoid bursitis
0.000 0.283 0.717
M06.1 Adult-onset Still's disease
0.000 0.283 0.717
E12 Malnutrition-related diabetes mellitus
0.000 0.283 0.717
M07.38 Other psoriatic arthropathies (Other)
0.000 0.283 0.717
M07.33 Other psoriatic arthropathies (Forearm)
0.000 0.283 0.717
M07.32 Other psoriatic arthropathies (Upper arm)
0.000 0.283 0.717
M07.31 Other psoriatic arthropathies (Shoulder region)
0.000 0.283 0.717
C44.8 Overlapping lesion of skin
0.000 0.283 0.717
E03.5 Myxoedema coma
0.000 0.283 0.717
E03.4 Atrophy of thyroid (acquired)
0.000 0.283 0.717
E03.3 Postinfectious hypothyroidism
0.000 0.283 0.717
M07.6 Other enteropathic arthropathies
0.000 0.283 0.717
M07.5 Arthropathy in ulcerative colitis
0.000 0.283 0.717
M07.4 Arthropathy in Crohn's disease [regional enteritis]
0.000 0.283 0.717
M07.2 Psoriatic spondylitis
0.000 0.283 0.717
M07.1 Arthritis mutilans
0.000 0.283 0.717
M07.0 Distal interphalangeal psoriatic arthropathy
0.000 0.283 0.717
L40.3 Pustulosis palmaris et plantaris
0.000 0.283 0.717
L40.2 Acrodermatitis continua
0.000 0.283 0.717
E05.5 Thyroid crisis or storm
0.000 0.283 0.717
E05.4 Thyrotoxicosis factitia
0.000 0.283 0.717
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.000 0.283 0.717
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.000 0.283 0.717
E04.0 Non-toxic diffuse goitre
0.000 0.283 0.717
M05.8 Other seropositive rheumatoid arthritis
0.000 0.284 0.716
M05.3 Rheumatoid arthritis with involvement of other organs and systems
0.000 0.284 0.716
M05.1 Rheumatoid lung disease
0.000 0.284 0.716
M05.0 Felty's syndrome
0.000 0.284 0.716
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)
0.000 0.284 0.716
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.284 0.716
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)
0.000 0.284 0.716
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)
0.000 0.284 0.716
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.284 0.716
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.285 0.715
E32 Diseases of thymus
0.000 0.285 0.715
E31 Polyglandular dysfunction
0.000 0.285 0.715
E30 Disorders of puberty, not elsewhere classified
0.000 0.285 0.715
E10.6 With other specified complications
0.000 0.287 0.713
M06.93 Rheumatoid arthritis, unspecified (Forearm)
0.000 0.287 0.713
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)
0.000 0.288 0.712
D04.3 Skin of other and unspecified parts of face
0.000 0.289 0.711
C83.3 Large cell (diffuse)
0.000 0.289 0.711
D04.5 Skin of trunk
0.000 0.289 0.711
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.290 0.710
E23.1 Drug-induced hypopituitarism
0.000 0.290 0.710
E11.0 With coma
0.000 0.291 0.709
E79 Disorders of purine and pyrimidine metabolism
0.000 0.291 0.708
M06.00 Seronegative rheumatoid arthritis (Multiple sites)
0.000 0.292 0.708
E05.8 Other thyrotoxicosis
0.000 0.292 0.708
E11.8 With unspecified complications
0.000 0.294 0.706
E89.3 Postprocedural hypopituitarism
0.000 0.294 0.705
G37.5 Concentric sclerosis [Balo]
0.705 0.295 0.000
G37.4 Subacute necrotising myelitis
0.705 0.295 0.000
G37.2 Central pontine myelinolysis
0.705 0.295 0.000
G37.1 Central demyelination of corpus callosum
0.705 0.295 0.000
G37.0 Diffuse sclerosis
0.705 0.295 0.000
L85 Other epidermal thickening
0.000 0.297 0.703
L44 Other papulosquamous disorders
0.000 0.298 0.701
L41 Parapsoriasis
0.000 0.298 0.701
L45 Papulosquamous disorders in diseases classified elsewhere
0.000 0.298 0.701
E27.9 Disorder of adrenal gland, unspecified
0.000 0.300 0.700
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)
0.000 0.301 0.699
E11.7 With multiple complications
0.000 0.303 0.697
E77 Disorders of glycoprotein metabolism
0.000 0.304 0.696
E76 Disorders of glycosaminoglycan metabolism
0.000 0.304 0.696
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.304 0.696
E70 Disorders of aromatic amino-acid metabolism
0.000 0.304 0.696
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.304 0.696
L57.5 Actinic granuloma
0.000 0.306 0.694
L57.3 Poikiloderma of Civatte
0.000 0.306 0.694
L57.2 Cutis rhomboidalis nuchae
0.000 0.306 0.694
L57.1 Actinic reticuloid
0.000 0.306 0.694
M06.8 Other specified rheumatoid arthritis
0.000 0.309 0.691
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.000 0.311 0.689
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified
0.000 0.313 0.687
E03.8 Other specified hypothyroidism
0.000 0.313 0.687
L94 Other localised connective tissue disorders
0.000 0.314 0.686
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.314 0.686
E28.2 Polycystic ovarian syndrome
0.000 0.315 0.685
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.000 0.317 0.683
C85.1 B-cell lymphoma, unspecified
0.000 0.317 0.683
E02 Subclinical iodine-deficiency hypothyroidism
0.000 0.318 0.682
D37-D48 Neoplasms of uncertain or unknown behaviour
0.000 0.318 0.682
E03.1 Congenital hypothyroidism without goitre
0.000 0.318 0.682
E27.5 Adrenomedullary hyperfunction
0.000 0.318 0.682
E27.0 Other adrenocortical overactivity
0.000 0.318 0.682
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.319 0.681
E03.0 Congenital hypothyroidism with diffuse goitre
0.000 0.319 0.681
L55 Sunburn
0.000 0.320 0.680
L85.8 Other specified epidermal thickening
0.000 0.321 0.679
E20 Hypoparathyroidism
0.000 0.321 0.679
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)
0.000 0.322 0.678
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.327 0.673
E89.4 Postprocedural ovarian failure
0.000 0.329 0.671
M12 Other specific arthropathies
0.000 0.334 0.666
G36.0 Neuromyelitis optica [Devic]
0.666 0.334 0.000
D04.7 Skin of lower limb, including hip
0.000 0.336 0.664
E10.4 With neurological complications
0.000 0.336 0.664
E78.4 Other hyperlipidaemia
0.000 0.337 0.663
E25 Adrenogenital disorders
0.000 0.342 0.657
L59 Other disorders of skin and subcutaneous tissue related to radiation
0.000 0.343 0.657
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system
0.000 0.345 0.655
G37.3 Acute transverse myelitis in demyelinating disease of central nervous system
0.652 0.348 0.000
M06.40 Inflammatory polyarthropathy (Multiple sites)
0.000 0.349 0.651
C43 Malignant melanoma of skin
0.000 0.350 0.650
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.352 0.648
E89.5 Postprocedural testicular hypofunction
0.000 0.352 0.648
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.352 0.648
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.000 0.353 0.647
L97 Ulcer of lower limb, not elsewhere classified
0.000 0.354 0.646
E88.8 Other specified metabolic disorders
0.000 0.355 0.645
D09 Carcinoma in situ of other and unspecified sites
0.000 0.359 0.640
M10.0 Idiopathic gout
0.000 0.360 0.640
C73 Malignant neoplasm of thyroid gland
0.000 0.361 0.639
E06.5 Other chronic thyroiditis
0.000 0.362 0.638
E06.4 Drug-induced thyroiditis
0.000 0.362 0.638
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.000 0.362 0.638
E06.0 Acute thyroiditis
0.000 0.362 0.638
E06.9 Thyroiditis, unspecified
0.000 0.366 0.634
E29.1 Testicular hypofunction
0.000 0.366 0.634
L56.9 Acute skin change due to ultraviolet radiation, unspecified
0.000 0.366 0.634
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)
0.000 0.367 0.633
E27.8 Other specified disorders of adrenal gland
0.000 0.368 0.632
M05.2 Rheumatoid vasculitis
0.000 0.370 0.630
M10.9 Gout, unspecified
0.000 0.371 0.629
M06.32 Rheumatoid nodule (Upper arm)
0.000 0.371 0.629
D43.0 Brain, supratentorial
0.000 0.371 0.629
E11.6 With other specified complications
0.000 0.373 0.627
E89.1 Postprocedural hypoinsulinaemia
0.000 0.374 0.625
M11 Other crystal arthropathies
0.000 0.375 0.625
L43.3 Subacute (active) lichen planus
0.000 0.375 0.625
L43.2 Lichenoid drug reaction
0.000 0.375 0.625
L43.1 Bullous lichen planus
0.000 0.375 0.625
L43.0 Hypertrophic lichen planus
0.000 0.375 0.625
L92 Granulomatous disorders of skin and subcutaneous tissue
0.000 0.375 0.625
E04.2 Non-toxic multinodular goitre
0.000 0.376 0.624
L58 Radiodermatitis
0.000 0.376 0.624
C91 Lymphoid leukaemia
0.000 0.376 0.624
D04.2 Skin of ear and external auricular canal
0.000 0.377 0.623
D04.4 Skin of scalp and neck
0.000 0.377 0.623
E89.2 Postprocedural hypoparathyroidism
0.000 0.378 0.622
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)
0.000 0.378 0.622
D01 Carcinoma in situ of other and unspecified digestive organs
0.000 0.381 0.619
E78.3 Hyperchylomicronaemia
0.000 0.381 0.618
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.382 0.618
C43.3 Malignant melanoma of other and unspecified parts of face
0.000 0.384 0.616
L94.2 Calcinosis cutis
0.000 0.386 0.614
M06.34 Rheumatoid nodule (Hand)
0.000 0.391 0.609
C82.0 Small cleaved cell, follicular
0.000 0.392 0.608
M06.08 Seronegative rheumatoid arthritis (Other)
0.000 0.392 0.608
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)
0.000 0.392 0.608
M06.03 Seronegative rheumatoid arthritis (Forearm)
0.000 0.392 0.608
M06.02 Seronegative rheumatoid arthritis (Upper arm)
0.000 0.392 0.608
M06.01 Seronegative rheumatoid arthritis (Shoulder region)
0.000 0.392 0.608
E13.9 Without complications
0.000 0.392 0.608
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)
0.000 0.394 0.606
E88.2 Lipomatosis, not elsewhere classified
0.000 0.395 0.605
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
0.000 0.395 0.605
D04.9 Skin, unspecified
0.000 0.397 0.603
E74 Other disorders of carbohydrate metabolism
0.000 0.397 0.602
D00 Carcinoma in situ of oral cavity, oesophagus and stomach
0.000 0.397 0.603
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.398 0.602
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.398 0.602
E88.9 Metabolic disorder, unspecified
0.000 0.399 0.601
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.400 0.600
E73 Lactose intolerance
0.000 0.401 0.599
L10-L14 Bullous disorders
0.000 0.402 0.598
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.000 0.402 0.598
E11.5 With peripheral circulatory complications
0.000 0.402 0.598
E72 Other disorders of amino-acid metabolism
0.000 0.404 0.596
E04.9 Non-toxic goitre, unspecified
0.000 0.406 0.594
E24.0 Pituitary-dependent Cushing's disease
0.000 0.408 0.592
C02 Malignant neoplasm of other and unspecified parts of tongue
0.000 0.415 0.585
D46 Myelodysplastic syndromes
0.000 0.416 0.584
E28.9 Ovarian dysfunction, unspecified
0.000 0.417 0.583
E28.8 Other ovarian dysfunction
0.000 0.417 0.583
E28.1 Androgen excess
0.000 0.417 0.583
E28.0 Oestrogen excess
0.000 0.417 0.583
E85 Amyloidosis
0.000 0.419 0.581
M06.37 Rheumatoid nodule (Ankle and foot)
0.000 0.420 0.580
M10.4 Other secondary gout
0.000 0.422 0.578
M10.2 Drug-induced gout
0.000 0.422 0.578
M10.1 Lead-induced gout
0.000 0.422 0.578
E21.3 Hyperparathyroidism, unspecified
0.000 0.422 0.578
E28.3 Primary ovarian failure
0.000 0.425 0.575
M06.39 Rheumatoid nodule (Site unspecified)
0.000 0.425 0.574
M06.38 Rheumatoid nodule (Other)
0.000 0.425 0.574
M06.36 Rheumatoid nodule (Lower leg)
0.000 0.425 0.574
M06.35 Rheumatoid nodule (Pelvic region and thigh)
0.000 0.425 0.574
M06.33 Rheumatoid nodule (Forearm)
0.000 0.425 0.574
M06.31 Rheumatoid nodule (Shoulder region)
0.000 0.425 0.574
M06.30 Rheumatoid nodule (Multiple sites)
0.000 0.425 0.574
G36.9 Acute disseminated demyelination, unspecified
0.574 0.426 0.000
G36.8 Other specified acute disseminated demyelination
0.574 0.426 0.000
G36.1 Acute and subacute haemorrhagic leukoencephalitis [Hurst]
0.574 0.426 0.000
E24.9 Cushing's syndrome, unspecified
0.000 0.426 0.574
E04.8 Other specified non-toxic goitre
0.000 0.426 0.574
L57.4 Cutis laxa senilis
0.000 0.427 0.573
D03 Melanoma in situ
0.000 0.428 0.572
E88.3 Tumour lysis syndrome
0.000 0.432 0.568
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.432 0.567
C83.7 Burkitt's tumour
0.000 0.433 0.567
D40 Neoplasm of uncertain or unknown behaviour of male genital organs
0.000 0.434 0.566
M14 Arthropathies in other diseases classified elsewhere
0.000 0.435 0.565
E29.9 Testicular dysfunction, unspecified
0.000 0.437 0.563
E29.8 Other testicular dysfunction
0.000 0.437 0.563
E29.0 Testicular hyperfunction
0.000 0.437 0.563
E84.9 Cystic fibrosis, unspecified
0.000 0.437 0.563
M10.3 Gout due to impairment of renal function
0.000 0.438 0.562
D02 Carcinoma in situ of middle ear and respiratory system
0.000 0.439 0.561
L95 Vasculitis limited to skin, not elsewhere classified
0.000 0.440 0.560
E24.2 Drug-induced Cushing's syndrome
0.000 0.443 0.557
L94.0 Localised scleroderma [morphea]
0.000 0.444 0.556
E26.0 Primary hyperaldosteronism
0.000 0.444 0.556
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.444 0.556
C94 Other leukaemias of specified cell type
0.000 0.444 0.556
D06.0 Endocervix
0.000 0.445 0.555
D04.8 Skin of other sites
0.000 0.445 0.555
D04.0 Skin of lip
0.000 0.445 0.555
L56.8 Other specified acute skin changes due to ultraviolet radiation
0.000 0.446 0.554
E24.8 Other Cushing's syndrome
0.000 0.446 0.554
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.446 0.554
E24.3 Ectopic ACTH syndrome
0.000 0.446 0.554
E24.1 Nelson's syndrome
0.000 0.446 0.554
E13.8 With unspecified complications
0.000 0.446 0.553
E13.7 With multiple complications
0.000 0.446 0.553
E13.6 With other specified complications
0.000 0.446 0.553
E13.5 With peripheral circulatory complications
0.000 0.446 0.553
E13.4 With neurological complications
0.000 0.446 0.553
E13.3 With ophthalmic complications
0.000 0.446 0.553
E13.2 With renal complications
0.000 0.446 0.553
E13.1 With ketoacidosis
0.000 0.446 0.553
E13.0 With coma
0.000 0.446 0.553
E78.8 Other disorders of lipoprotein metabolism
0.000 0.447 0.553
M06.48 Inflammatory polyarthropathy (Other)
0.000 0.449 0.550
M06.47 Inflammatory polyarthropathy (Ankle and foot)
0.000 0.449 0.550
M06.46 Inflammatory polyarthropathy (Lower leg)
0.000 0.449 0.550
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)
0.000 0.449 0.550
M06.44 Inflammatory polyarthropathy (Hand)
0.000 0.449 0.550
M06.43 Inflammatory polyarthropathy (Forearm)
0.000 0.449 0.550
M06.42 Inflammatory polyarthropathy (Upper arm)
0.000 0.449 0.550
M06.41 Inflammatory polyarthropathy (Shoulder region)
0.000 0.449 0.550
D06.7 Other parts of cervix
0.000 0.449 0.550
D06.1 Exocervix
0.000 0.449 0.550
C83.1 Small cleaved cell (diffuse)
0.000 0.449 0.550
M10.90 Gout, unspecified (Multiple sites)
0.000 0.450 0.550
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.000 0.450 0.550
C85.0 Lymphosarcoma
0.000 0.450 0.550
C91.9 Lymphoid leukaemia, unspecified
0.000 0.452 0.548
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.000 0.453 0.547
L87 Transepidermal elimination disorders
0.000 0.453 0.547
L86 Keratoderma in diseases classified elsewhere
0.000 0.453 0.547
C12 Malignant neoplasm of pyriform sinus
0.000 0.453 0.547
M06.04 Seronegative rheumatoid arthritis (Hand)
0.000 0.455 0.545
L92.3 Foreign body granuloma of skin and subcutaneous tissue
0.000 0.455 0.545
L56.3 Solar urticaria
0.000 0.456 0.544
L56.2 Photocontact dermatitis [berloque dermatitis]
0.000 0.456 0.544
L56.1 Drug photoallergic response
0.000 0.456 0.544
L56.0 Drug phototoxic response
0.000 0.456 0.544
L80 Vitiligo
0.000 0.457 0.543
C86 Other specified types of T/NK-cell lymphoma
0.000 0.458 0.542
E21.4 Other specified disorders of parathyroid gland
0.000 0.458 0.541
C93 Monocytic leukaemia
0.000 0.459 0.541
C82.2 Large cell, follicular
0.000 0.465 0.535
C88 Malignant immunoproliferative diseases
0.000 0.465 0.535
C07 Malignant neoplasm of parotid gland
0.000 0.468 0.532
E26.9 Hyperaldosteronism, unspecified
0.000 0.469 0.531
E26.8 Other hyperaldosteronism
0.000 0.469 0.531
E26.1 Secondary hyperaldosteronism
0.000 0.469 0.531
E21.2 Other hyperparathyroidism
0.000 0.472 0.528
M13 Other arthritis
0.000 0.473 0.527
E84.8 Cystic fibrosis with other manifestations
0.000 0.474 0.526
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.474 0.526
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.474 0.526
E27.2 Addisonian crisis
0.000 0.475 0.525
L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
0.000 0.477 0.523
C83.6 Undifferentiated (diffuse)
0.000 0.477 0.523
C83.5 Lymphoblastic (diffuse)
0.000 0.477 0.523
C83.4 Immunoblastic (diffuse)
0.000 0.477 0.523
C83.2 Mixed small and large cell (diffuse)
0.000 0.477 0.523
E40-E46 Malnutrition
0.000 0.479 0.521
D09.0 Bladder
0.000 0.479 0.521
M10.09 Idiopathic gout (Site unspecified)
0.000 0.480 0.520
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.000 0.480 0.520
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.480 0.520
C02.9 Tongue, unspecified
0.000 0.480 0.520
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.482 0.518
C03 Malignant neoplasm of gum
0.000 0.484 0.516
D47.1 Chronic myeloproliferative disease
0.000 0.484 0.516
L83 Acanthosis nigricans
0.000 0.484 0.516
L92.0 Granuloma annulare
0.000 0.484 0.516
D01.0 Colon
0.000 0.484 0.515
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.000 0.486 0.514
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.000 0.486 0.514
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.000 0.486 0.514
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.000 0.486 0.514
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.000 0.486 0.514
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.000 0.486 0.514
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.000 0.486 0.514
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.000 0.486 0.514
M08.9 Juvenile arthritis, unspecified
0.000 0.486 0.514
M08.8 Other juvenile arthritis
0.000 0.486 0.514
M08.4 Pauciarticular juvenile arthritis
0.000 0.486 0.514
M08.3 Juvenile polyarthritis (seronegative)
0.000 0.486 0.514
M08.2 Juvenile arthritis with systemic onset
0.000 0.486 0.514
M08.1 Juvenile ankylosing spondylitis
0.000 0.486 0.514
M08.0 Juvenile rheumatoid arthritis
0.000 0.486 0.514
M09.8 Juvenile arthritis in other diseases classified elsewhere
0.000 0.486 0.514
M09.2 Juvenile arthritis in ulcerative colitis
0.000 0.486 0.514
M09.1 Juvenile arthritis in Crohn's disease [regional enteritis]
0.000 0.486 0.514
M09.0 Juvenile arthritis in psoriasis
0.000 0.486 0.514
M06.19 Adult-onset Still's disease (Site unspecified)
0.000 0.486 0.514
M06.18 Adult-onset Still's disease (Other)
0.000 0.486 0.514
M06.17 Adult-onset Still's disease (Ankle and foot)
0.000 0.486 0.514
M06.16 Adult-onset Still's disease (Lower leg)
0.000 0.486 0.514
M06.15 Adult-onset Still's disease (Pelvic region and thigh)
0.000 0.486 0.514
M06.14 Adult-onset Still's disease (Hand)
0.000 0.486 0.514
M06.13 Adult-onset Still's disease (Forearm)
0.000 0.486 0.514
M06.12 Adult-onset Still's disease (Upper arm)
0.000 0.486 0.514
M06.11 Adult-onset Still's disease (Shoulder region)
0.000 0.486 0.514
M06.10 Adult-onset Still's disease (Multiple sites)
0.000 0.486 0.514
M06.29 Rheumatoid bursitis (Site unspecified)
0.000 0.486 0.514
M06.28 Rheumatoid bursitis (Other)
0.000 0.486 0.514
M06.27 Rheumatoid bursitis (Ankle and foot)
0.000 0.486 0.514
M06.26 Rheumatoid bursitis (Lower leg)
0.000 0.486 0.514
M06.25 Rheumatoid bursitis (Pelvic region and thigh)
0.000 0.486 0.514
M06.24 Rheumatoid bursitis (Hand)
0.000 0.486 0.514
M06.23 Rheumatoid bursitis (Forearm)
0.000 0.486 0.514
M06.22 Rheumatoid bursitis (Upper arm)
0.000 0.486 0.514
M06.21 Rheumatoid bursitis (Shoulder region)
0.000 0.486 0.514
M06.20 Rheumatoid bursitis (Multiple sites)
0.000 0.486 0.514
E12.9 Without complications
0.000 0.486 0.514
E12.8 With unspecified complications
0.000 0.486 0.514
E12.7 With multiple complications
0.000 0.486 0.514
E12.6 With other specified complications
0.000 0.486 0.514
E12.5 With peripheral circulatory complications
0.000 0.486 0.514
E12.4 With neurological complications
0.000 0.486 0.514
E12.3 With ophthalmic complications
0.000 0.486 0.514
E12.2 With renal complications
0.000 0.486 0.514
E12.1 With ketoacidosis
0.000 0.486 0.514
E12.0 With coma
0.000 0.486 0.514
M07.09 Distal interphalangeal psoriatic arthropathy (Site unspecified)
0.000 0.486 0.514
M07.08 Distal interphalangeal proriatic arthropathy-Other
0.000 0.486 0.514
M07.07 Distal interphalangeal psoriatic arthropathy (Ankle and foot)
0.000 0.486 0.514
M07.06 Distal interphalangeal proriatic arthropathy-Lower leg
0.000 0.486 0.514
M07.05 Distal interphalangeal proriatic arthropathy-Pelvic/thigh
0.000 0.486 0.514
M07.04 Distal interphalangeal psoriatic arthropathy (Hand)
0.000 0.486 0.514
M07.03 Distal interphalangeal proriatic arthropathy-Forearm
0.000 0.486 0.514
M07.02 Distal interphalangeal proriatic arthropathy-Upper arm
0.000 0.486 0.514
M07.01 Distal interphalangeal proriatic arthropathy-Shldr region
0.000 0.486 0.514
M07.00 Distal interphalangeal psoriatic arthropathy (Multiple sites)
0.000 0.486 0.514
M07.19 Arthritis mutilans (Site unspecified)
0.000 0.486 0.514
M07.18 Arthritis mutilans (Other)
0.000 0.486 0.514
M07.17 Arthritis mutilans (Ankle and foot)
0.000 0.486 0.514
M07.16 Arthritis mutilans (Lower leg)
0.000 0.486 0.514
M07.15 Arthritis mutilans (Pelvic region and thigh)
0.000 0.486 0.514
M07.14 Arthritis mutilans (Hand)
0.000 0.486 0.514
M07.13 Arthritis mutilans (Forearm)
0.000 0.486 0.514
M07.12 Arthritis mutilans (Upper arm)
0.000 0.486 0.514
M07.11 Arthritis mutilans (Shoulder region)
0.000 0.486 0.514
M07.10 Arthritis mutilans (Multiple sites)
0.000 0.486 0.514
M07.29 Psoriatic spondylitis (Site unspecified)
0.000 0.486 0.514
M07.28 Psoriatic spondylitis (Other)
0.000 0.486 0.514
M07.27 Psoriatic spondylitis (Ankle and foot)
0.000 0.486 0.514
M07.26 Psoriatic spondylitis (Lower leg)
0.000 0.486 0.514
M07.25 Psoriatic spondylitis (Pelvic region and thigh)
0.000 0.486 0.514
M07.24 Psoriatic spondylitis (Hand)
0.000 0.486 0.514
M07.23 Psoriatic spondylitis (Forearm)
0.000 0.486 0.514
M07.22 Psoriatic spondylitis (Upper arm)
0.000 0.486 0.514
M07.21 Psoriatic spondylitis (Shoulder region)
0.000 0.486 0.514
M07.20 Psoriatic spondylitis (Multiple sites)
0.000 0.486 0.514
M07.49 Arthropathy in Crohn's disease [regional enteritis] (Site unspecified)
0.000 0.486 0.514
M07.48 Arthropathy in Crohn's disease [regional enteritis] (Other)
0.000 0.486 0.514

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.